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a  b  s  t  r  a  c  t
Leprosy, whose etiological agent is Mycobacterium leprae, is a chronic infectious disease that
mainly affects the skin and peripheral nervous system. The diagnosis of leprosy is based on
clinical evaluation, whereas histopathological analysis and bacilloscopy are complementary
diagnostic tools. Quantitative PCR (qPCR), a current useful tool for diagnosis of infectious
diseases, has been used to detect several pathogens including Mycobacterium leprae. The
validation of this technique in a robust set of samples comprising the different clinical forms
of  leprosy is still necessary. Thus, in this study samples from 126 skin biopsies (collected from
patients on all clinical forms and reactional states of leprosy) and 25 slit skin smear of leprosy
patients were comparatively analyzed by qPCR (performed with primers for the RLEP region
of  M. leprae DNA) and routine bacilloscopy performed in histological sections or in slit skin
smear. Considering clinical diagnostic as the gold standard, 84.9% of the leprosy patients
were qPCR positive in skin biopsies, resulting in 84.92% sensitivity, with 84.92 and 61.22%
positive (PPV) and negative (NPV) predictive values, respectively. Concerning bacilloscopy of
histological sections (BI/H), the sensitivity was 80.15% and the PPV and NPV were 80.15 and
44.44%, respectively. The concordance between qPCR and BI/H was 87.30%. Regarding the
slit  skin smear, 84% of the samples tested positive in the qPCR. Additionally, qPCR showed
100%  speciﬁcity, since all samples from different mycobacteria, from healthy individuals,
and  from other granulomatous diseases presented negative results. In conclusion, the qPCR
technique for detection of M. leprae using RLEP primers proved to be speciﬁc and sensitive,
and qPCR can be used as a complementary test to diagnose leprosy irrespective of the clinicalPlease cite this article in press as: Azevedo MC, et al. qPCR detection of My
clinical forms. Braz J Infect Dis. 2016. http://dx.doi.org/10.1016/j.bjid.2016.0
form of disease.
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Introduction
Leprosy, whose etiologic agent is Mycobacterium leprae (M. lep-
rae), is a chronic infectious disease that affects primarily the
skin and the peripheral nervous system. The clinical spectrum
proposed by Ridley and Jopling (R&J) consists of two poles:
tuberculoid (TT) and lepromatous (LL), and three intermediate
forms: borderline-tuberculoid (BT), borderline-borderline (BB),
and borderline-lepromatous (BL).1 In addition, there are clini-
cal forms associated with two reactional forms: type 1 reaction
(or reversal reaction – RR) and type 2 reaction (or erythema
nodosum leprosum – ENL).2
So far, M. leprae cannot grow in vitro, and this is a limiting
factor to the study of the disease. The diagnosis of lep-
rosy is based on clinical evaluation of patients, whereas
histopathological analysis and bacilloscopy are complemen-
tary diagnostic exams. In this context, the bacilloscopy of
histological sections (BI/H) and bacilloscopy of slit skin smear
(BI/S) have an important role for patient’s diagnosis and
follow up, and for choosing the adequate chemotherapeutic
regimen. In spite of that, these techniques are time consum-
ing and have limited sensitivity. Additionally, in tuberculoid
patients, in which bacilli are rare or nonexistent, there is
always a limitation in using bacilloscopy as an auxiliary exam,
once negative results do not rule out the disease. Then, the
implementation of new, more  sensitive techniques to detect
M. leprae are necessary to reduce the time for a deﬁnitive
diagnosis.
Currently, quantitative PCR (qPCR) has been considered
a rapid, sensitive and speciﬁc method for detection of
pathogens, including M. leprae.3,4 However, validation of this
technique in a large number of samples collected from dif-
ferent clinical forms of the leprosy spectrum and reactional
states (RR and ENL) is still necessary.
In order to improve the odds of the molecular detection of
M. leprae DNA, the gene sequence selected for the design of
primers in this study was based on the overlapping of Spe-
ciﬁc Repetitive Element (RLEP) regions located along the M.
leprae genome. The use of RLEP has the advantage of being
more  sensitive than targets located in other gene regions
because it provides multiple copies.5–8 Assays using the RLEP
target proved to be more  sensitive in the detection of M.  lep-
rae when compared to other single copy targets like Ag85B,
sodA and 16S rRNA.5 Furthermore, PCR assays based on the
use of RLEP have shown rapid and objective results as a tool
for molecular detection and quantiﬁcation of mycobacteria
in clinical samples.9 Additionally, this sequence was chosen
because it has no homology to other mycobacteria or bacte-
rial species providing, therefore, the speciﬁcity required for a
test designed to improve the diagnosis of leprosy via M.  leprae
detection.
Thus, the objective of this study was to validate a RLEP
based qPCR for the detection of M. leprae in skin lesions biop-
sies collected from patients on all clinical forms of leprosy and
reactional states, and also in slit skin smears. The importance
of this work is that a large number of samples were evaluatedPlease cite this article in press as: Azevedo MC, et al. qPCR detection of My
clinical forms. Braz J Infect Dis. 2016. http://dx.doi.org/10.1016/j.bjid.2016.
by qPCR, and skin biopsies were representative of all clinical
forms of leprosy, including reactional manifestations of the
disease. In addition, in order to compare the ability to detect 6;x x x(x x):xxx–xxx
M.  leprae in other types of samples, qPCR was also tested in
DNA extracted from slit skin smear slides.
Material  and  methods
Patients
Biopsies of skin lesions (single 5 or 6 mm3 punchs) of lep-
rosy patients were collected (in RNAlater) during one year
at the Lauro de Souza Lima Institute and Health Center
Jardim Guanabara. A total of 126 skin biopsies used to assess
BI/H from patients classiﬁed according to R&J criteria1 were
included. Of those, there were 38 tuberculoid (TT), 21 bor-
derline tuberculoid (BT), 18 borderline borderline (BB), 12
borderline lepromatous (BL), and 13 lepromatous (LL). Biop-
sies of reactional patients were collected either at diagnosis,
during or after the course of multidrug therapy (MDT); how-
ever, none of the patients had received any corticosteroids or
thalidomide to treat the reactional event. Reactional patients
were divided into two subgroups: 12 reversal reaction (RR) and
12 erythema nodosum leprosum (ENL). Additionally, for anal-
ysis the samples (n = 126) were also divided into paucibacillary
(PB), with BI/H 0 to 1+, and multibacillary (MB) with BI/H equal
or higher than 2+.
For baciloscopic index of slit skin smear (BI/S), 25 samples
were collected randomly in the period of one month from the
Microbiology Laboratory of the Lauro de Souza Lima Institute.
These samples had positive BI/S ranging from 1+ to 5+, and
were collected from index points: earlobes, elbows, knees, and
lesion.10 Of note, these samples were multibacillary and did
not match skin lesions biopsies of patients submitted to skin
biopsy.
Furthermore, for both BI/H and BI/S, negative bacilloscopy
results show baciloscopic indexes (BI) equal 0+, and positive
results show BI between 1+ and 6+. BI was deﬁned according to
the literature, so that 0+ means absence of bacilli in 100 ﬁelds
evaluated; 1+ presence of 1–10 bacilli in 100 ﬁelds evaluated;
2+ presence of 1–10 bacilli in 10 ﬁelds evaluated; 3+ presence
of 1–10 bacilli per ﬁeld on average; 4+ presence of 10–100 bacilli
per ﬁeld on average; 5+ presence of 100–1000 bacilli per ﬁeld
on average; 6+ presence more  than 1000 bacilli per ﬁeld on
average.
Additionally, 10 skin biopsies from patients with other
granulomatous skin diseases [pemphigus foliaceus (2), pem-
phigus vulgaris (1), nummular eczema (1), licheniﬁed eczema
(1), porphyria (2), and erythematous lupus (3)] and 10 skin biop-
sies from healthy individuals (undergoing cosmetic surgery
without previous diagnosis of leprosy or any other skin dis-
ease) were used as negative controls. This study was approved
by the Ethical Committee of Lauro de Souza Lima Institute
(protocol n◦ 046/2009) and informed consent was obtained
from all participants.
Mycobacteria  samplescobacterium leprae in biopsies and slit skin smear of different leprosy
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Puriﬁed DNA from M. leprae11 was used as positive control
and DNA from different mycobacterial species (M.  tubercu-
losis, M.  fortuitum, M.  avium,  M.  smegmatis,  M. intracellulare,
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.  chimera, M.  nonchromogenicum,  M. colombiense and M.  absces-
us subspboletti) were used as negative controls.
xtraction  of  DNA  from  skin  biopsies
xtraction of total DNA from the biopsies was performed
sing approximately 20 mg of material using the DNeasy Blood
nd Tissue kit (Qiagen, Valencia, CA, USA) according to the
anufacturer’s speciﬁcations, including a step of overnight
roteinase K pre-digestion under agitation (1400 rpm) at 56 ◦C.
fter extraction, the concentration and purity of the samples
ere assessed using the Nanodrop2000 equipment (Thermo
isher Scientiﬁc, Waltham, MA,  USA). To perform the qPCR
echnique, the DNA concentration used was 10 ng of total DNA,
nd depending on DNA concentration, variable volume (uL)
as used to perform the qPCR.
NA  extraction  from  slit  skin  smear  slides
or DNA extraction from slit skin smear slides, excess immer-
ion oil used for counting bacilli, was removed by pressure
ith absorbent paper. Then, 90 l ultrapure water was added
n top of the smear which was scrapped off with an unused
calpel blade, and the content was pipetted into the tubes
here the suspensions were centrifuged at 10,000 rpm for
0 min. After the centrifugation step, the supernatant was
iscarded and the pellet subjected to DNA extraction using
he DNeasy Blood and Tissue kit (Qiagen, Valencia, CA, USA)
ccording to the manufacturer’s instructions. After extraction,
he samples were concentrated by vacuum method in the
iVAC DNA Concentrator (Genevac, Ipswich, Suffolk, UK) for
 h at room temperature, obtaining a ﬁnal volume of approx-
mately 50 l. The concentration and purity of the samples
ere assessed using the Nanodrop 2000 equipment (Thermo
isher Scientiﬁc, Waltham, MA,  USA). To perform the qPCR
echnique, the DNA concentration used was 10 ng of total DNA,
nd depending on DNA concentration, variable volume (uL)
as used to perform the qPCR.
uantitative  PCR  (real-time  PCR  assays)
he gene sequence selected for construction of the primers
as based on overlapping of RLEPs 1, 2, 3 and 4. The pair of
rimers was designed using the Primer Express 2.0 (Thermo
isher Scientiﬁc, Waltham, MA,  USA), followed by conﬁrma-
ion of homology through the software Basic Local Alignment
earch Tool (NCBI/BLAST). These primers differ from others
reviously described.5–7,9,12,13
Assays for detection of M. leprae were performed in
uplicates using 10 ng of total DNA (for samples from
kin lesions and slit skin smear) in the StepOnePlus
quipment (Thermo Fisher Scientiﬁc, Waltham, MA, USA),
sing SYBRGreen chemistry and the pair of primers (sense
′ATTTCTGCCGCTGGTATCGGT 3′, antisense 5′ TGCGCTA-
AAGGTTGCCGTAT 3′) (ThermoFisher Scientiﬁc, Waltham,
A,  USA).
◦Please cite this article in press as: Azevedo MC, et al. qPCR detection of My
clinical forms. Braz J Infect Dis. 2016. http://dx.doi.org/10.1016/j.bjid.2016.0
The reaction consisted of two minutes at 50 C, two minutes
t 95 ◦C, and 40 cycles of 30 s at 95 ◦C, 30 s 62.5 ◦C (anneal-
ng temperature) and one minute at 72 ◦C, and a ﬁnal cycle of
0 min  with increasing temperature from 60 to 95 ◦C to obtain;x  x x(x x):xxx–xxx 3
the dissociation of the reaction (melting curve). The melting
curve was used for the analysis of speciﬁcity of the ampliﬁca-
tion products curve. The results were obtained in accordance
with the ﬁrst ﬂuorescent signal detection Cycle Threshold (CT)
and the sample was considered positive when it showed CT
smaller than 40 (cutoff). The quality of the DNA sample was
veriﬁed using primers speciﬁc for the constitutive Beta-actin
gene (sense 5′ GGTGTCACCAAAGCAAAGGC 3′, antisense 5′
TAAGGGAGCTTTCGGAGCTGT 3′).
Standard  curve  and  limit  of  detection
To check the detection limit, a standard curve was pre-
pared from the puriﬁed DNA of M. leprae extracted after
processing a footpad of nude mice (six months after inocula-
tion). The footpad was removed and the suspension (1 × 109)
was processed in 500 l sterile saline solution using a tis-
sue homogenizer (Turrax/IKA, Guangzhou, China) running
ﬁve pulses 15′ ′/speed 4.10 The DNA was extracted using the
DNeasy Blood and Tissue kit (Qiagen, Valencia, CA, USA)
according to the manufacturer’s speciﬁcations, including a
step of overnight Proteinase K pre-digestion under agitation
(1400 rpm) at 56 ◦C. The standard curve consisted of six points,
and it was performed by serial dilution (1:10) with the initial
and ﬁnal points 0.3 ng and 3 fg, respectively. This curve was
performed in three different days to conﬁrm reproducibility.
Statistical  analysis
The correlations between CT values and bacilloscopy (BI/H and
BI/S), and CT and DNA concentration of M.  leprae were cal-
culated using the Spearman’s test. For detection of M. leprae
in the paucibacillary and multibacillary samples, according to
the CT values, the Mann Whitney test was used. For detec-
tion of M.  leprae in clinical forms of the disease and in slit
skin smears, according to the CT values, the Kruskal–Wallis
test was used. All analyses were performed using the Graph-
Pad Prism 5.0 (GraphPad Software, California, USA). Sensitivity,
speciﬁcity, concordance, positive predictive value, and neg-
ative predictive value were determined using the GraphPad
Quick Calcs (GraphPad Software, California, USA). Addition-
ally, these parameters were also calculated to each group,
after selecting equal numbers of samples by random selec-
tion (random.org) to avoid under or overrepresentation of any
group in the overall analysis. This procedure was performed
four times to ensure homogeneous distribution and the values
were expressed as average value.
Results
qPCR  in  skin  lesions
As shown in Fig. 1, the limit of detection for qPCR was equal
to 300 fg, since the technique did not detect concentrationscobacterium leprae in biopsies and slit skin smear of different leprosy
9.017
below 300 fg (30 fg and 3 fg). Additionally, the standard curve
showed reproducibility and there was a statistically signiﬁcant
negative correlation between CT and DNA concentration of M.
leprae (p = 0.0028).
Please cite this article in press as: Azevedo MC, et al. qPCR detection of My
clinical forms. Braz J Infect Dis. 2016. http://dx.doi.org/10.1016/j.bjid.2016.
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Table 1 – Number of samples (skin lesions) detected by quantitative PCR.
Clinical form Positive qPCR/total
number (%)
qPCR  positive/total number (%)
BI/H 0+ BI/H 1+ BI/H 2+ BI/H 3+ BI/H 4+ BI/H 5+ BI/H 6+
TT 21/38 (55.2) 9/22 (40.9) 12/16 (75) – – – – –
BT 20/21 (95.2) – 4/4 (100) 12/13 (92.3) 4/4 (100) – – –
BB 18/18 (100) – – 2/2 (100) 2/2 (100) 6/6 (100) 8/8 (100)
BL 12/12 (100) – – – – – 6/6 (100) 6/6 (100)
LL 13/13 (100) – – – – – – 13/13 (100)
RR 11/12 (91.7) 2/3 (66.6) 2/2 (100) 1/1(100) 1/1 (100) 2/2 (100) 3/3 (100) –
ENL 12/12 (100) – – 4/4 (100) 6/6 (100) – – 2/2 (100)
Total 107/126 (84.9) 11/25 (44) 18/22 (81.8) 19/20 (95) 13/13 (100) 8/8 (100) 17/17 (100) 21/21 (100)
qPCR, quantitative PCR; TT, tuberculoid; BT, borderline-tuberculoid; BB, borderline-borderline; BL, borderline-lepromatous; LL, lepromatous; RR,
reversal reaction; ENL, erythema nodosum leprosum.
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Fig. 1 – Quantitative PCR standard curve. A standard curve
was prepared from the puriﬁed DNA of M.  leprae.  It was
performed by serial dilution (1:10) with the initial and ﬁnal
points 0.3 ng and 3 fg, respectively, and the limit of
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Fig. 2 – Detection of M.  leprae in biopsy samples by qPCR techniq
negative results. (A) Patients divided in seven groups (n = 107). (B
multibacillary (BI/H ≥ 2+) forms, excluding negative results (n = 10
tuberculoid, BT: borderline-tuberculoid, BB: borderline-borderline
reaction, ENL: erythema nodosum leprosum. #p < 0.05.logical sections (BI/H).
When evaluating the positivity of the samples selected for
this study by qPCR, 84.9% were M.  leprae positive, being 55.2%
TT, 95.2% BT, 91.7% RR, and 100% BB, BL, LL, and ENL groups
(Table 1). Regarding the PB and MB group, 61.7% (29/47) and
98.7 (78/79) were M.  leprae positive, respectively. As shown
in Fig. 2A, considering only the qPCR positive results, the
CT averages observed in different clinical groups were 33.8
(24.9–37.1) for TT, 32.4 (24.7–35.9) for BT, 23.9 (19.3–30.9) for
BB, 20.3 (16.3–24.9) for BL, and 16.7 (11.5–21.2) for LL. In the
reactional patients, the RR group had a higher CT (CT average
28.3) than the ENL group in whom the average value was 26.5.
When all groups were evaluated, there was a statistically sig-
niﬁcant negative correlation between CT and BI/H (p < 0.0001).
A signiﬁcant difference was observed between CT values of
multibacillary (CT average 23.7) and paucibacillary patients (CT
average 34) (Fig. 2B).
Additionally, when considering only TT patients with neg-
ative BI/H (0+) the qPCR was capable of detecting 9 (40.9%) out
of 22 samples. In TT patients with BI/H1+, the qPCR was ablecobacterium leprae in biopsies and slit skin smear of different leprosy
09.017
to detect 12 (75%) out of 16 samples (Table 1). When consid-
ering only the 101 BI/H positive samples (BI/H 1+ to 6+), 95%
















ue. Data reported in scatter dot plot as medians, excluding
) Patients grouped as paucibacillary (BI/H ≤ 1+) and
7). BI/H: bacilloscopy of histological sections, TT:
, BL: borderline-lepromatous, LL: lepromatous, RR: reversal
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Table 2 – Speciﬁcity of quantitative PCR.
Species (n = 10) CT value









Mycobacterium abscessus subspboletti >40
Other dermatological diseases (n = 10)
Pemphigus foliaceus (n = 2) >40
Pemphigus vulgaris (n = 1) >40
Nummular eczema (n = 1) >40
Licheniﬁed eczema (n = 1) >40
Porphyria (n = 2) >40
Lupus erythematosus (n = 3) >40
Healthy individuals (n = 10)
Normal skin >40
qPCR, quantitative PCR; CT, cycle threshold.
Speciﬁcity of the primers relative to other species of mycobacteria,
dermatological diseases (non leprosy) and healthy individuals.
Table 3 – Comparison between qPCR and BI/H
techniques.
Contrasts qPCR positive (+) qPCR negative (−) Total
BI/H positive (+) 96 5 101
BI/H negative (−) 11 14 25
Total 107 19 126



























1+ 2+ 3+ 4+ 5+
Fig. 3 – Detection of M.  leprae in slit skin smear samples by
qPCR technique. Data reported in scatter dot plot as
medians, excluding negative results (n = 21). Samples
qPCR showed positivity in 9/22 samples (40.9%), demonstrat-
ing an improved sensitivity of this method compared to BI/H.time PCR; BI/H, bacilloscopy of histological sections.
as a statistically signiﬁcant negative correlation between CT
nd BI/H (p < 0.0001).
Regarding speciﬁcity, qPCR showed to be 100% speciﬁc, as
. leprae was not detected in any negative controls including
ifferent mycobacteria, healthy individuals, and other granu-
omatous diseases, with CT value higher than 40 (Table 2).
When qPCR and bacilloscopy (BI/H) were compared in the
roup of 126 leprosy patients, 96 patients were positive and
4 patients were negative for both technique, with a con-
ordance of 87.30% (110/126) between qPCR and BI/H. The
iscordance was 12.6% (16/126) with ﬁve patients BI/H pos-
tive and qPCR negative, and 11 patients BI/H negative and
PCR positive (Table 3). For all the patients (126) qPCR sen-
itivity was 84.9%, and the positive (PPV) and negative (NPV)
redictive values were 84.9 and 61.2%, respectively (Table 4).
oncerning bacilloscopy (BI/H), the sensitivity was 80.1%, and
he positive (PPV) and negative (NPV) predictive values were
0.1 and 44.4%, respectively (Table 4). Additionally, when equal
umber of samples was randomly selected (n = 10), sensitivity
nd PPV for qPCR (both 52.5%) and BI/H (both 37.5%) decreased
or TT group, while NPV values increased (86.3 for qPCR andPlease cite this article in press as: Azevedo MC, et al. qPCR detection of My
clinical forms. Braz J Infect Dis. 2016. http://dx.doi.org/10.1016/j.bjid.2016.0
1.5% for BI/H). For the RR group, sensitivity and PPV for qPCR
ncreased (both 95%) and decreased (both 75%) for BI/H, andgrouped according to bacilloscopy of slit skin smears (BI/S).
for both NPV values increased (98.3 for qPCR and 80% for BI/H).
Regarding other groups all the parameters were 100% (Table 4).
qPCR  in  slit  skin  smear
Regarding the CT values obtained from the DNA of slit skin
smears, good results were observed with detection of 84% of
the samples tested, 60% in BI/S1+, 50% in BI/S2+, 88.8% in
BI/S3+, 100% in BI/S4+, and BI/S5+ (Table 5). As shown in Fig. 3,
considering only the qPCR positive results, the CT averages
observed in different BI/S were 35.5 (34.1–37.6) to BI/S1+, 31.8
(34.7–37.7) to BI/S2+, 29.2 (26.4–34.8) to BI/S3+, 25.8 (24.3–27.5)
to BI/S4+, and 26.9 (26.3–30.2) to BI/S5+. Additionally, there was
a statistically signiﬁcant negative correlation between CT and
BI/S (p < 0.0001).
Discussion
In this study, we  describe the use of the qPCR technique for
detection of M.  leprae in biopsy samples and slit skin smear
of from leprosy patients with the different clinical forms of
the disease. Our results demonstrate that this is a simple and
reproducible technique using detection of M. leprae genomic
DNA. Additionally, in contrast to other studies,3–5,14,15 this
work included a large number of patient samples (n = 126) from
different forms of the leprosy spectrum, including reactional
states (RR and ENL), besides the operational classiﬁcation
as paucibacillary (PB) and multibacillary (MB). This strategy
allowed the evaluation of a robust set of samples.
In this work, for skin lesions, 84.92% of the leprosy patients
were qPCR positive, showing high sensitivity. Moreover, qPCR
showed signiﬁcant correlation and good concordance (87.30%)
with direct bacillary counting (BI/H). Regarding lower pos-
itivity displayed by the TT group (n = 38, 55.2%), compared
to the other clinical forms evaluated, this was probably due
to the high number of BI/H 0+ patients (n = 22). In addition,cobacterium leprae in biopsies and slit skin smear of different leprosy
9.017
Opposed to that, other study obtained higher percentage of TT
positive samples5; however, it included only two  TT patients
ARTICLE IN PRESSBJID-664; No. of Pages 8
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Table 4 – Sensitivity, PPV and NPV values for the qPCR and BI/H (skin lesions).
BI/H qPCR
Patients Sensitivity (%) PPV (%) NPV (%) Sensitivity (%) PPV (%) NPV (%)
Total (n = 126) 80.1 80.1 44.4 84.9 84.9 61.2
TT (n = 10) * 37.5 37.5 61.5 52.5 52.5 86.3
BT (n = 10) * 100 100 100 100 100 100
BB (n = 10) * 100 100 100 100 100 100
BL (n = 10) * 100 100 100 100 100 100
LL (n = 10) * 100 100 100 100 100 100
RR (n = 10) * 75 75 80 95 95 98.3
ENH (n = 10) * 100 100 100 100 100 100
qPCR, real time PCR; BI/H, bacilloscopy of histological sections; PPV, positive predictive value; NPV, negative predictive value.
∗ To avoid overrepresentation of the groups with small sample size, the sensitivity, PPV and NPV values for the individual groups (leprosy
clinical forms and reactional forms) were calculated after a random selection of the samples to comprise groups with the equal n = 10.
Table 5 – Number of samples (slit skin smear) detected by quantitative PCR.
Positive qPCR/total number (%) qPCR positive/total number (%)
BI/S1+ BI/S 2+ BI/S 3+ BI/S 4+ BI/S 5+
21/25 (84) 3/5 (60) 1/2 (50) 8/9 (88.8) 7/7 (100) 2/2 (100)qPCR, quantitative PCR; BI/S, bacilloscopy of slit skin smear.
and one pure neural leprosy case. Note that after random
selection, by analyzing each group separately, the value of
the qPCR sensitivity decreased for the TT patients when com-
pared to the sensitivity for all samples (n = 126). On the other
hand, for the TT patients, BI/H sensitivity was lower than
qPCR, showing again an improved sensitivity of this method
compared with BI/H.
Some of the BI/H 1+ and 2+ were qPCR negative (n = 5),
affecting the sensitivity of this method. One of the reasons
for this result was the collection of two skin biopsies from
the same patient’s lesion, for different purposes (qPCR and
bacilloscopy), so that the number of bacilli might have varied
between them. It is important to consider that positive qPCR
in lesions with BI/H 0+, as discussed above, may also have
resulted positive because different biopsies were collected
from the same lesion. Additionally, the negative bacilloscopy
sometimes obtained in a sample in the tuberculoid side of
leprosy, does not indicate that the method is not capable of
detecting bacilli; instead, it shows that the patient may have
minimum bacillary load. Also, a negative bacilloscopy in lep-
rosy may be found in immunocompetent patients (polar TT
patients, capable of spontaneous cure) after clearance.
Similar to the TT group, in the present study two RR sam-
ples were qPCR positive, despite being BI/H 0+, showing again
the good sensitivity of the method. Interestingly, the result of
the RR group, shown in Fig. 2A, reveals the variability within
the group, which corroborates the clinical ﬁndings in the RR
forms.16 In one hand, qPCR positive and low CT values sam-
ples were related to regressive disease. On the other hand, in
the same RR group, samples with high CT values were related
to progressive disease.Please cite this article in press as: Azevedo MC, et al. qPCR detection of My
clinical forms. Braz J Infect Dis. 2016. http://dx.doi.org/10.1016/j.bjid.2016.
Based on the present results, it was observed that using the
qPCR methodology, it was not possible to establish a cutoff
CT for leprosy clinical forms, reactional forms or for opera-
tional classiﬁcation of patients as PB and MB, since there waslarge variation in the samples CT when assessed individu-
ally (Fig. 2). Similar to that, other study using pPCR for the
85B gene showed signiﬁcant difference between MB  and PB
patients, but again it was not possible to establish a cutoff CT
for leprosy.4 On the other hand, this technique showed to be
useful for detection of paucibacillary samples, especially from
TT patients. Therefore, the qPCR technique used for the detec-
tion of M. leprae may contribute for the detection of bacilli in
PB patients (BI/H 0+ and 1+).
In respect to speciﬁcity, the qPCR resulted negative (with
CT > 40) in all non-leprae mycobacteria used in the assay. Addi-
tionally, samples from other dermatological diseases and from
healthy individuals were all negative, demonstrating 100%
speciﬁcity. Note that bacilloscopy is also considered a 100%
speciﬁc method, even without comparison with negative con-
trols, since there are not other tests for detection of acid-fast
bacilli in BI/H or BI/S as there is for leprosy, therefore no false-
positive results occur.
Other studies also used qPCR technique based on RLEP
region,5,12 but there are some differences between them and
the present study. For example, they used TaqMan qPCR and
this study used Sybr Green qPCR. Although different chem-
istry was used, the number of positive results was similar
to different forms of the leprosy spectrum, especially for the
BB, BL and LL groups (100% positive). For the TT group, as
mentioned above, Martinez et al. (2011)5 showed higher per-
centage of TT positive samples (66.7%); however, they included
only two TT patients and one pure neural leprosy case, while
this study included 38 TT patients. In another study,12 the
percentage of positive results in the TT group was similar
(50% TT positive). On the other hand, among the PB group,cobacterium leprae in biopsies and slit skin smear of different leprosy
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a higher rate of positive results were reported (74.5%) when
compared with this study (61.7%). Additionally, the present
study showed 100% speciﬁcity compared to 73%5 of that study,
and although our detection limit (300 fg) was bigger than other
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tudies,5,12 this result did not affect signiﬁcantly the method
ensitivity.
In this work, RLEP gene was chosen because this region
epeats 37 times along the bacillus genome.8 Therefore, the
dvantage of using qPCR based on RLEP is that it would amplify
he power of detection when compared to assays based on
he use of a single copy gene.6,13,16 Indeed the study using
rimers to sodA, 16S, and Ag85B showed lower positivity in BT
atients, with positive results ranging between 18% and 36.4%,
nd no TT patients were positive to these target genes.5 On the
ther hand, other studies using primers to 16S14 and Proline-
ich antigen15 showed similar results to PB patients (with BI
+), with positive results ranging between 44%15 and 53%.14
owever, another study showed higher number of positive PB
atients (80%),4 but in this case, differently from this study,
t was necessary to decrease the CT value to avoid detection
f negative controls. Yet, most of the aforementioned stud-
es showed similar results for MB  patients, except one, that
howed lower positive results (46%).15
Concerning the study design, it is important to emphasize
hat only one study classiﬁed patients based on BI of histo-
ogical sections,12 while in other studies the classiﬁcation of
atients was based on BI of the slit skin smear. However, in
his case the PCR performed on skin biopsies could have dif-
erent bacilloscopic indexes. In the present study, both the
lassiﬁcation of the patients and qPCR were based on skin
iopsies, thus the results cannot be fully compared to previous
tudies.4,5,14,15
In respect to DNA ampliﬁcation in slit skin smear slides,
atisfactory results were observed (84% of positive samples) by
PCR; however, all samples were BI/S positive. Similar results
ere previously obtained by other authors, with 83% of sam-
les showing positive ampliﬁcation using simple PCR assay.13
n the other hand, in another study using qPCR for 85A-C only
8.5% of the MB  patients showed positive results.17 For further
onﬁrmation of our results, it would be necessary to include
amples with all baciloscopic indexes, including BI zero (PB
atients). It is important to point out that the DNA used for
PCR was extracted from slit skin smear slides, therefore pre-
ious ﬁxing and staining may have impaired the quality of the
NA. Indeed, Ruiz-Fuents et al. (2015)18 showed that differ-
nt extraction methods to obtain M. leprae DNA can affect its
mpliﬁcation. Thus, the present study shows that the extrac-
ion of DNA from slit skin smear slides, after microscopic
nalysis, can be used as an alternative to detect the M.  lep-
ae bacillus, even though this is not the ideal type of sample
or this purpose. Therefore, it may be used when a biopsy is
navailable. Furthermore, DNA extracted from slit skin smear
an be used in other molecular techniques, such as veriﬁcation
f mutations associated with drug resistance.
In conclusion, qPCR technique for detection of M.  leprae
roved to be speciﬁc and sensitive, and has an additional
dvantage as a large number of samples can be processed
imultaneously within a period of three hours, whereas for the
acilloscopy the time required to stain and count bacilli is con-
iderably higher, particularly for PB cases. On the other hand,
he qPCR technique has some limitations as it requires equip-Please cite this article in press as: Azevedo MC, et al. qPCR detection of My
clinical forms. Braz J Infect Dis. 2016. http://dx.doi.org/10.1016/j.bjid.2016.0
ent, techniques and reagents of high cost unlike microscopy.
n some cases qPCR may become limited to a few Reference
enters making it difﬁcult to be performed in ﬁeld. However,;x  x x(x x):xxx–xxx 7
it is perfectly applicable to research purposes and experimen-
tal quantiﬁcation of M.  leprae DNA. Additionally, qPCR cannot
detect all PB patients and, according to what was mentioned
above, it was not possible to establish a cutoff CT for leprosy
clinical forms, reactional forms or for operational classiﬁca-
tion of patients (PB and MB), since there was large variation in
the samples CT when assessed individually. However, outside
of Reference Centers often there is no expertise in evaluat-
ing samples of leprosy patients, thus the qPCR technique,
when well executed, can decrease the chance of false-negative
results when used as a complementary diagnostic tool.
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